STERIS plc — Intrinsic Value & Fair Price

STE

NYSEHealthcareMedical - SpecialtiesCIK 0001757898steris.comAbout STE

Last close · Oct 16, 2026222.66−1.67 (−0.74%)

Market cap$21.7B

Model value · DCF · Perpetuity growth · 5y

187.62

Steris closed at $222.66 — overvalued by 19% vs model.

122.33the model's range402.68

DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models

55.50 – 558.98

Wall St. target

270.00 18% below

Above model, 1y

16 of 20 days

Price and model value

Loading chart…

What the marks mean

Daily close

Valuation models

price $222.66 · as of Oct 17, 2026

DCF · Perpetuity growth · 5yused122.33 – 402.68187.6219% overvalued DCF · Perpetuity growth · 10y136.65 – 423.61204.339% overvalued DCF · EBITDA exit · 5y196.51 – 371.81277.0520% undervalued DCF · EBITDA exit · 10y193.04 – 392.28278.5020% undervalued P/E · peers262.71 – 574.44517.8357% undervalued P/E · own history385.36 – 823.43558.9860% undervalued PEG—228.873% undervalued EV/EBITDA · peers168.89 – 271.95237.276% undervalued EV/Revenue · peers102.58 – 243.77127.9974% overvalued Earnings power value47.82 – 74.4358.81279% overvalued Dividend discount38.08 – 91.3155.50301% overvalued Wall St. consensus target—270.0018% below Cost of capital (WACC)—8.60%—

DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. How we value a stock walks through every input.

engine pkg:0.1.0

Dividends

Quarterly · as of Oct 16, 2026

Yield, trailing 12 months

1.16%

Past 2 years

low 0.86%high 1.26%

Dividends per share, a year at a time

Dividends / free cash flow, FY2026: 24.9%
Raised: 20+ years in a row
Growth, 5 yrs: 9.6% a year
Last change: +9.5% · Sep 2026

Every payment, with ex-dates · latest $0.69, paid Sep 25, 2026

Research on STE

No posts on STE yet.

Studied STE from its filings? Guest posts are reviewed before they go live.Write about STE →

How it is valued

Valued asMature & stable

Low/slowing growth (~7% recent)Moderate margins (13% net margin)Pays dividendsHighly cyclical earnings

What growth the price implies: the reverse DCF

Key figures

FY2026 · chosen for mature companies

P/E

28.1×

EV / EBITDA

21.1×

FCF yield

4.4%

Dividend yield, TTM

1.16%

Beta

0.93

Cost of capital (WACC)

8.60%

Full financials

Superinvestors

13F · Q2 2026

BridgewaterBridgewater Associates, LP$2.1M First EagleFirst Eagle Investment Management, LLC$20,005

All 2 holders

Analyst actions

third-party, quoted

07-28UBS · target275.00

05-21Piper Sandler · target270.00

05-13KeyBanc · target269.00

07-15Morgan Stanley · “Overweight” from “Equal Weight”upgrade

Ratings, targets and estimates

Recent

filings, insider trades and key news

10-138-K · 1.01Entry into a Material Agreement 10-01Form 4 · FBurton Karen L · 228 sh@ 0.00 08-12Form 4 · MSohi Mohsen · 4,058 sh@ 86.23 08-12Form 4 · SSohi Mohsen · 4,058 sh@ 235.78 08-10Form 4 · ASohi Mohsen · 1,099 sh@ 0.00 08-10Form 4 · ASohi Mohsen · 1,229 sh@ 0.00

46 filings · 40 insider transactions

Comparable companies

by business, not by industry label

BDXBecton Dickinson SOLVSolventum BAXBaxter International WSTWest Pharmaceutical Services ECLEcolab

The weekly

One email a week across every stock we cover: 13F filings, insider trades, earnings and new research. It covers the whole market, not just STE. No account.

About Steris

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

CEO: Daniel A. Carestio
Headquarters: Mentor, OH
Employees: 17,937
IPO: 1992-06-01

Full company profile

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; the formulas are in how we value a stock.